Primary |
Contraception |
51.3% |
Drug Use For Unknown Indication |
32.1% |
Menstruation Irregular |
3.0% |
Asthma |
1.6% |
Pain |
1.4% |
Menorrhagia |
1.3% |
Product Used For Unknown Indication |
1.3% |
Depression |
1.0% |
Dysmenorrhoea |
1.0% |
Menstrual Disorder |
0.7% |
Hypertension |
0.7% |
Polycystic Ovaries |
0.7% |
Migraine |
0.7% |
Multiple Allergies |
0.6% |
Endometriosis |
0.6% |
Headache |
0.5% |
Urinary Tract Infection |
0.4% |
Menometrorrhagia |
0.4% |
Libido Decreased |
0.4% |
Ovarian Cyst |
0.4% |
|
Pulmonary Embolism |
35.5% |
Deep Vein Thrombosis |
13.8% |
Thrombosis |
12.1% |
Injury |
7.8% |
Cerebrovascular Accident |
5.1% |
Unintended Pregnancy |
4.2% |
Unevaluable Event |
3.3% |
Myocardial Infarction |
2.1% |
Pregnancy With Contraceptive Patch |
1.8% |
Thrombophlebitis Superficial |
1.7% |
Vomiting |
1.6% |
Off Label Use |
1.5% |
Vaginal Haemorrhage |
1.5% |
Urinary Tract Infection |
1.4% |
Transient Ischaemic Attack |
1.4% |
Convulsion |
1.2% |
Venous Thrombosis |
1.1% |
Intracranial Venous Sinus Thrombosis |
0.9% |
Subarachnoid Haemorrhage |
0.9% |
Superior Sagittal Sinus Thrombosis |
0.9% |
|
Secondary |
Contraception |
38.8% |
Menstruation Irregular |
11.0% |
Drug Use For Unknown Indication |
8.2% |
Dysmenorrhoea |
6.5% |
Polycystic Ovaries |
3.7% |
Menorrhagia |
3.5% |
Asthma |
2.9% |
Depression |
2.8% |
Menstrual Disorder |
2.6% |
Diabetes Mellitus Insulin-dependent |
2.5% |
Drug Therapy |
2.2% |
Hormone Level Abnormal |
2.2% |
Migraine |
1.9% |
Hypertension |
1.8% |
Acne Cystic |
1.7% |
Amenorrhoea |
1.7% |
Off Label Use |
1.7% |
Product Used For Unknown Indication |
1.7% |
Endometriosis |
1.4% |
Hormone Therapy |
1.3% |
|
Pulmonary Embolism |
21.4% |
Thrombosis |
12.6% |
Off Label Use |
10.7% |
Vaginal Haemorrhage |
8.0% |
Vomiting |
7.6% |
Convulsion |
4.2% |
Wrong Technique In Drug Usage Process |
3.8% |
Deep Vein Thrombosis |
3.1% |
Nausea |
3.1% |
Inappropriate Schedule Of Drug Administration |
2.7% |
Rhinitis Allergic |
2.7% |
Unintended Pregnancy |
2.7% |
Pregnancy With Contraceptive Patch |
2.3% |
Sickle Cell Anaemia With Crisis |
2.3% |
Therapeutic Response Unexpected |
2.3% |
Transient Ischaemic Attack |
2.3% |
Urinary Tract Infection |
2.3% |
Weight Increased |
2.3% |
Pyrexia |
1.9% |
Sepsis |
1.9% |
|
Concomitant |
Contraception |
27.9% |
Product Used For Unknown Indication |
16.4% |
Crohn's Disease |
6.4% |
Drug Use For Unknown Indication |
6.4% |
Depression |
4.0% |
Pain |
4.0% |
Acne |
3.5% |
Multiple Sclerosis |
3.5% |
Anxiety |
3.1% |
Asthma |
3.1% |
Oral Contraception |
2.9% |
Colitis Ulcerative |
2.7% |
Migraine |
2.7% |
Premenstrual Syndrome |
2.4% |
Paroxysmal Nocturnal Haemoglobinuria |
2.2% |
Multiple Allergies |
2.0% |
Anticoagulant Therapy |
1.8% |
Headache |
1.8% |
Acne Cystic |
1.6% |
Post Coital Contraception |
1.6% |
|
Vomiting |
14.3% |
Cholelithiasis |
10.2% |
Pregnancy |
9.2% |
Menstruation Irregular |
7.1% |
Cholecystitis Chronic |
6.1% |
Rash |
5.1% |
Off Label Use |
4.1% |
Pharmaceutical Product Complaint |
4.1% |
Procedural Pain |
4.1% |
Pulmonary Embolism |
4.1% |
Somnolence |
4.1% |
Abdominal Pain Upper |
3.1% |
Abortion Induced |
3.1% |
Deep Vein Thrombosis |
3.1% |
Dehydration |
3.1% |
Malaise |
3.1% |
Nausea |
3.1% |
Pain |
3.1% |
Vaginal Discharge |
3.1% |
Vasodilatation |
3.1% |
|
Interacting |
|
|